Population
Patients with long QT syndrome (LQT)
Design
Review
Authors
Loading...
Supports genotype-specific LQT therapies; leaves open need for prospective trials before practice change.
This review summarizes the genetic basis of long QT syndrome and highlights genotype-specific management strategies such as mexiletine for LQT3 and potassium supplementation for LQT2.
Wang et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: